BioSpace News Archive

Harpoon Therapeutics, Inc. (NASDAQ: HARP), today presented interim data from the ongoing dose-escalation portion of a Phase 1/2a trial for HPN424 in patients with metastatic castration-resistant prostate cancer (mCRPC) at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women.

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today presented results from analyses evaluating the immune effects of trilaciclib in patients with extensive-stage small cell lung cancer (ES-SCLC) following two Phase 2 clinical trials

Galapagos NV announced that primary and secondary endpoint results from the phase 3 SELECTIONinduction and maintenance study were published in The Lancet00666-8).The study, sponsored by Gilead Sciences, Inc., was designed to assess the efficacy and safety of the once-daily, oral preferential JAK1 inhibitor, filgotinib, under investigation in patients with moderately to severely active ulcerative colitis.

Alligator Bioscience presents novel supportive data from the ongoing Phase I clinical trial with the 4-1BB drug candidate ATOR-1017 developed as tumor-directed therapy for metastatic cancer.

Getinge has launched a new framework for social financing and a new social bond of SEK 570 million. The capital will be used to expand the production capacity of products that save lives.

According to the report, the global sinusitis treatment market was valued at US$ 2.9 Bn in 2020 and is projected to expand at a CAGR of ~4% from 2021 to 2031.

According to the report, the global interventional pulmonology market was valued over US$ 3 Bn in 2020 and is projected to expand at a CAGR of ~9% from 2021 to 2031.

According to the report, the global in vitro fertilization test market was valued over US$ 1.5 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.

According to the report, the global fluorine-18 market was valued over US$ 1.5 Bn in 2020 and is projected to expand at a CAGR of 7.5% from 2021 to 2031.